News for Physicians from the Johns Hopkins Department of Physical Medicine and Rehabilitation
Johns Hopkins is among the first in the U.S. to develop technologies that collect and store data regarding multiple facets of physical function. The aim: to spur novel research and advance rehabilitation.
The trial will determine the safety and efficacy for people with postural orthostatic tachycardia syndrome of a drug that blocks antibody production and decreases autoantibodies.
Director Stacy Suskauer leads a group with 11 pediatric physiatrists at four Johns Hopkins locations.
